Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David Westergaard is active.

Publication


Featured researches published by David Westergaard.


Nature Communications | 2015

Novel variation and de novo mutation rates in population-wide de novo assembled Danish trios

Søren Besenbacher; Siyang Liu; Jose M. G. Izarzugaza; Jakob Grove; Kirstine Belling; Jette Bork-Jensen; Shujia Huang; Thomas Damm Als; Shengting Li; Rachita Yadav; Arcadio Rubio-García; Francesco Lescai; Ditte Demontis; Junhua Rao; Weijian Ye; Thomas Mailund; Rune M. Friborg; Christian N. S. Pedersen; Ruiqi Xu; Jihua Sun; Hao Liu; Ou Wang; Xiaofang Cheng; David Flores; Emil Rydza; Kristoffer Rapacki; John Damm Sørensen; Piotr Jaroslaw Chmura; David Westergaard; Piotr Dworzynski

Building a population-specific catalogue of single nucleotide variants (SNVs), indels and structural variants (SVs) with frequencies, termed a national pan-genome, is critical for further advancing clinical and public health genetics in large cohorts. Here we report a Danish pan-genome obtained from sequencing 10 trios to high depth (50 × ). We report 536k novel SNVs and 283k novel short indels from mapping approaches and develop a population-wide de novo assembly approach to identify 132k novel indels larger than 10 nucleotides with low false discovery rates. We identify a higher proportion of indels and SVs than previous efforts showing the merits of high coverage and de novo assembly approaches. In addition, we use trio information to identify de novo mutations and use a probabilistic method to provide direct estimates of 1.27e−8 and 1.5e−9 per nucleotide per generation for SNVs and indels, respectively.


Nature | 2017

Sequencing and de novo assembly of 150 genomes from Denmark as a population reference

Lasse Maretty; Jacob Malte Jensen; Bent Petersen; Jonas Andreas Sibbesen; Siyang Liu; Palle Villesen; Laurits Skov; Kirstine Belling; Christian Theil Have; Jose M. G. Izarzugaza; Marie Grosjean; Jette Bork-Jensen; Jakob Grove; Thomas Damm Als; Shujia Huang; Yuqi Chang; Ruiqi Xu; Weijian Ye; Junhua Rao; Xiaosen Guo; Jihua Sun; Hongzhi Cao; Chen Ye; Johan van Beusekom; Thomas Espeseth; Esben N. Flindt; Rune M. Friborg; Anders E. Halager; Stephanie Le Hellard; Christina M. Hultman

Hundreds of thousands of human genomes are now being sequenced to characterize genetic variation and use this information to augment association mapping studies of complex disorders and other phenotypic traits. Genetic variation is identified mainly by mapping short reads to the reference genome or by performing local assembly. However, these approaches are biased against discovery of structural variants and variation in the more complex parts of the genome. Hence, large-scale de novo assembly is needed. Here we show that it is possible to construct excellent de novo assemblies from high-coverage sequencing with mate-pair libraries extending up to 20 kilobases. We report de novo assemblies of 150 individuals (50 trios) from the GenomeDenmark project. The quality of these assemblies is similar to those obtained using the more expensive long-read technology. We use the assemblies to identify a rich set of structural variants including many novel insertions and demonstrate how this variant catalogue enables further deciphering of known association mapping signals. We leverage the assemblies to provide 100 completely resolved major histocompatibility complex haplotypes and to resolve major parts of the Y chromosome. Our study provides a regional reference genome that we expect will improve the power of future association mapping studies and hence pave the way for precision medicine initiatives, which now are being launched in many countries including Denmark.


Human Molecular Genetics | 2017

Klinefelter syndrome comorbidities linked to increased X chromosome gene dosage and altered protein interactome activity

Kirstine González-Izarzugaza Belling; Francesco Russo; Anders Boeck Jensen; Marlene Danner Dalgaard; David Westergaard; Ewa Rajpert-De Meyts; Niels E. Skakkebæk; Anders Juul; Søren Brunak

Abstract Klinefelter syndrome (KS) (47,XXY) is the most common male sex chromosome aneuploidy. Diagnosis and clinical supervision remain a challenge due to varying phenotypic presentation and insufficient characterization of the syndrome. Here we combine health data-driven epidemiology and molecular level systems biology to improve the understanding of KS and the molecular interplay influencing its comorbidities. In total, 78 overrepresented KS comorbidities were identified using in- and out-patient registry data from the entire Danish population covering 6.8 million individuals. The comorbidities extracted included both clinically well-known (e.g. infertility and osteoporosis) and still less established KS comorbidities (e.g. pituitary gland hypofunction and dental caries). Several systems biology approaches were applied to identify key molecular players underlying KS comorbidities: Identification of co-expressed modules as well as central hubs and gene dosage perturbed protein complexes in a KS comorbidity network build from known disease proteins and their protein–protein interactions. The systems biology approaches together pointed to novel aspects of KS disease phenotypes including perturbed Jak-STAT pathway, dysregulated genes important for disturbed immune system (IL4), energy balance (POMC and LEP) and erythropoietin signalling in KS. We present an extended epidemiological study that links KS comorbidities to the molecular level and identify potential causal players in the disease biology underlying the identified comorbidities.


PLOS Computational Biology | 2018

A comprehensive and quantitative comparison of text-mining in 15 million full-text articles versus their corresponding abstracts

David Westergaard; Hans Henrik Stærfeldt; Christian Tønsberg; Lars Juhl Jensen; Søren Brunak

Across academia and industry, text mining has become a popular strategy for keeping up with the rapid growth of the scientific literature. Text mining of the scientific literature has mostly been carried out on collections of abstracts, due to their availability. Here we present an analysis of 15 million English scientific full-text articles published during the period 1823–2016. We describe the development in article length and publication sub-topics during these nearly 250 years. We showcase the potential of text mining by extracting published protein–protein, disease–gene, and protein subcellular associations using a named entity recognition system, and quantitatively report on their accuracy using gold standard benchmark data sets. We subsequently compare the findings to corresponding results obtained on 16.5 million abstracts included in MEDLINE and show that text mining of full-text articles consistently outperforms using abstracts only.


Nature Reviews Drug Discovery | 2018

Unexplored therapeutic opportunities in the human genome

Tudor I. Oprea; Cristian G. Bologa; Søren Brunak; Allen Campbell; Gregory Gan; Anna Gaulton; Shawn M. Gomez; Rajarshi Guha; Anne Hersey; Jayme Holmes; Ajit Jadhav; Lars Juhl Jensen; Gary L. Johnson; Anneli Karlson; Andrew R. Leach; Avi Ma'ayan; Anna Malovannaya; Subramani Mani; Stephen L. Mathias; Michael T. McManus; Terrence F. Meehan; Christian von Mering; Daniel Muthas; Dac Trung Nguyen; John P. Overington; George Papadatos; Jun Qin; Christian Reich; Bryan L. Roth; Stephan C. Schürer

A large proportion of biomedical research and the development of therapeutics is focused on a small fraction of the human genome. In a strategic effort to map the knowledge gaps around proteins encoded by the human genome and to promote the exploration of currently understudied, but potentially druggable, proteins, the US National Institutes of Health launched the Illuminating the Druggable Genome (IDG) initiative in 2014. In this article, we discuss how the systematic collection and processing of a wide array of genomic, proteomic, chemical and disease-related resource data by the IDG Knowledge Management Center have enabled the development of evidence-based criteria for tracking the target development level (TDL) of human proteins, which indicates a substantial knowledge deficit for approximately one out of three proteins in the human proteome. We then present spotlights on the TDL categories as well as key drug target classes, including G protein-coupled receptors, protein kinases and ion channels, which illustrate the nature of the unexplored opportunities for biomedical research and therapeutic development.


Journal of Ovarian Research | 2014

The transcriptome of corona radiata cells from individual MІІ oocytes that after ICSI developed to embryos selected for transfer: PCOS women compared to healthy women.

Marie Louise Wissing; Si Brask Sonne; David Westergaard; Kho do Nguyen; Kirstine Belling; Thomas Høst; Anne Lis Mikkelsen

BackgroundCorona radiata cells (CRCs) refer to the fraction of cumulus cells just adjacent to the oocyte. The CRCs are closely connected to the oocyte throughout maturation and their gene expression profiles might reflect oocyte quality. Polycystic ovary syndrome (PCOS) is a common cause of infertility. It is controversial whether PCOS associate with diminished oocyte quality. The purpose of this study was to compare individual human CRC samples between PCOS patients and controls.MethodsAll patients were stimulated by the long gonadotropin-releasing hormone (GnRH) agonist protocol. The CRC samples originated from individual oocytes developing into embryos selected for transfer. CRCs were isolated in a two-step denudation procedure, separating outer cumulus cells from the inner CRCs. Extracted RNA was amplified and transcriptome profiling was performed with Human Agilent® arrays.ResultsThe transcriptomes of CRCs showed no individual genes with significant differential expression between PCOS and controls, but gene set enrichment analysis identified several cell cycle- and DNA replication pathways overexpressed in PCOS CRCs (FDR < 0.05). Five of the genes contributing to the up-regulated cell cycle pathways in the PCOS CRCs were selected for qRT-PCR validation in ten PCOS and ten control CRC samples. qRT-PCR confirmed significant up-regulation in PCOS CRCs of cell cycle progression genes HIST1H4C (FC = 2.7), UBE2C (FC = 2.6) and cell cycle related transcription factor E2F4 (FC = 2.5).ConclusionThe overexpression of cell cycle-related genes and cell cycle pathways in PCOS CRCs could indicate a disturbed or delayed final maturation and differentiation of the CRCs in response to the human chorionic gonadotropin (hCG) surge. However, this had no effect on the in vitro development of the corresponding embryos. Future studies are needed to clarify whether the up-regulated cell cycle pathways in PCOS CRCs have any clinical implications.


Genome Research | 2017

Assembly and analysis of 100 full MHC haplotypes from the Danish population

Jacob Malte Jensen; Palle Villesen; Rune M. Friborg; Thomas Mailund; Søren Besenbacher; Mikkel H. Schierup; Lasse Maretty; Bent Petersen; Jonas Andreas Sibbesen; Siyang Liu; Laurits Skov; Kirstine Belling; Christian Theil Have; Jose M. G. Izarzugaza; Marie Grosjean; Jette Bork-Jensen; Jakob Grove; Thomas D. Als; Shujia Huang; Yuqi Chang; Ruiqi Xu; Weijian Ye; Junhua Rao; Xiaosen Guo; Jihua Sun; Hongzhi Cao; Chen Ye; Johan van Beusekom; Thomas Espeseth; Esben N. Flindt

Genes in the major histocompatibility complex (MHC, also known as HLA) play a critical role in the immune response and variation within the extended 4-Mb region shows association with major risks of many diseases. Yet, deciphering the underlying causes of these associations is difficult because the MHC is the most polymorphic region of the genome with a complex linkage disequilibrium structure. Here, we reconstruct full MHC haplotypes from de novo assembled trios without relying on a reference genome and perform evolutionary analyses. We report 100 full MHC haplotypes and call a large set of structural variants in the regions for future use in imputation with GWAS data. We also present the first complete analysis of the recombination landscape in the entire region and show how balancing selection at classical genes have linked effects on the frequency of variants throughout the region.


Oncotarget | 2018

Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers

Kalliopi Tsafou; Anna M. Katschnig; Branka Radic-Sarikas; Cornelia N. Mutz; Kristiina Iljin; Raphaela Schwentner; Maximilian Kauer; Karin Mühlbacher; Dave N.T. Aryee; David Westergaard; Saija Haapa-Paananen; Vidal Fey; Giulio Superti-Furga; Jeffrey A. Toretsky; Søren Brunak; Heinrich Kovar

Ewing sarcoma (EwS) is an aggressive pediatric bone cancer in need of more effective therapies than currently available. Most research into novel targeted therapeutic approaches is focused on the fusion oncogene EWSR1-FLI1, which is the genetic hallmark of this disease. In this study, a broad range of 3,325 experimental compounds, among them FDA approved drugs and natural products, were screened for their effect on EwS cell viability depending on EWS-FLI1 expression. In a network-based approach we integrated the results from drug perturbation screens and RNA sequencing, comparing EWS-FLI1-high (normal expression) with EWS-FLI1-low (knockdown) conditions, revealing novel interactions between compounds and EWS-FLI1 associated biological processes. The top candidate list of druggable EWS-FLI1 targets included genes involved in translation, histone modification, microtubule structure, topoisomerase activity as well as apoptosis regulation. We confirmed our in silico results using viability and apoptosis assays, underlining the applicability of our integrative and systemic approach. We identified differential sensitivities of Ewing sarcoma cells to BCL-2 family inhibitors dependent on the EWS-FLI1 regulome including altered MCL-1 expression and subcellular localization. This study facilitates the selection of effective targeted approaches for future combinatorial therapies of patients suffering from Ewing sarcoma.


bioRxiv | 2017

Text mining of 15 million full-text scientific articles

David Westergaard; Hans-Henrik Stærfeldt; Christian Tønsberg; Lars Juhl Jensen; Søren Brunak

Across academia and industry, text mining has become a popular strategy for keeping up with the rapid growth of the scientific literature. Text mining of the scientific literature has mostly been carried out on collections of abstracts, due to their availability. Here we present an analysis of 15 million English scientific full-text articles published during the period 1823–2016. We describe the development in article length and publication sub-topics during these nearly 250 years. We showcase the potential of text mining by extracting published protein–protein, disease–gene, and protein subcellular associations using a named entity recognition system, and quantitatively report on their accuracy using gold standard benchmark data sets. We subsequently compare the findings to corresponding results obtained on 16.5 million abstracts included in MEDLINE and show that text mining of full-text articles consistently outperforms using abstracts only.


Tumor Biology | 2015

Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways.

David Westergaard; Mathilde Borg Houlberg Thomsen; Mette Vistesen; Khoa Nguyen Do; Louise Fogh; Kirstine Belling; Jun Wang; Huanming Yang; Ramneek Gupta; Henrik J. Ditzel; José M. A. Moreira; Nils Brünner; Jan Stenvang; Anne-Sofie Schrohl

Collaboration


Dive into the David Westergaard's collaboration.

Top Co-Authors

Avatar

Søren Brunak

University of Copenhagen

View shared research outputs
Top Co-Authors

Avatar

Kirstine Belling

Technical University of Denmark

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jose M. G. Izarzugaza

Technical University of Denmark

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Siyang Liu

University of Copenhagen

View shared research outputs
Top Co-Authors

Avatar

Anders Juul

University of Copenhagen

View shared research outputs
Researchain Logo
Decentralizing Knowledge